8.37 am: Serum Institute of India’s Chief Executive Officer Adar Poonawalla on Wednesday said that the Oxford and AstraZeneca’s coronavir...
8.37 am: Serum Institute of India’s Chief Executive Officer Adar Poonawalla on Wednesday said that the Oxford and AstraZeneca’s coronavirus vaccine, which his company is producing, may be ready by December. He told NDTV that the company may also apply for emergency use licence.
“If we don’t go for an emergency licence, our trials should be over by December and then we can maybe we can launch in India in January subject to the UK trial also being completed which it’s on the verge on being completed,” he told the news channel.
Poonawalla added: “If the UK in the next two weeks were to unblind their study and share the data and be confident that it’s safe, then we can, after two-three weeks, apply to the Indian regulator to look at a possible emergency licence if that’s what the government of India wants.”
8.32 am: France announces a second lockdown to battle a surge in coronavirus cases, Reuters reports. The restrictions will come into force on Friday and last till December 1.
8.30 am: A serological survey conducted by the Government Medical College in Srinagar has found that over 40% of the residents have developed antibodies for the coronavirus, The Indian Express reports. The survey in June had showed that only...
